XML 29 R10.htm IDEA: XBRL DOCUMENT v2.3.0.15
Shareholders' Equity
9 Months Ended
Sep. 30, 2011
Shareholders' Equity [Abstract] 
Shareholders' Equity

5. Shareholders' Equity

Stock Options

We have a stock plan (the "Stock Plan") and an inducement stock plan for newly hired employees (the "Inducement Plan") (together the "Plans"). Under the Plans, stock options may be granted with a fixed exercise price that is equivalent to fair market value on the date of grant. These options have a term of up to 10 years and vest over a predetermined period, generally four years. Incentive stock options granted under the Stock Plan may only be granted to our employees. The Stock Plan also allows for awards of non-qualified stock options, stock appreciation rights, RSAs and unrestricted stock awards, and RSUs. The Stock Plan allows for an automatic annual increase in the number of shares reserved for issuance under the Stock Plan. Such automatic annual increase is in an amount equal to the lesser of: (i) four percent of our outstanding shares at the end of the previous fiscal year, (ii) an amount determined by our Board of Directors, or (iii) 375,000 shares. The Inducement Plan was established during the three months ended September 30, 2011 in connection with the MPC acquisition. The Inducement Plan may only be used to grant non-qualified stock option awards to new employees. Initially, 250,000 shares were allocated for award under the Inducement Plan. The number of shares available for award may be modified by our Board of Directors, subject to SEC and NASDAQ limitations.

 

Stock-Based Compensation

The estimated fair value of stock-based awards is recognized as compensation expense over the vesting period of the award, net of estimated forfeitures. We estimate forfeitures based on historical experience and expected future activity. The fair values of RSAs and RSUs are determined based on the number of shares granted and the quoted price of our common stock on the date of grant, less our estimation of future forfeitures. The fair value of stock option awards is estimated at the grant date based on the fair value of each vesting tranche as calculated by the Black-Scholes-Merton ("BSM") option-pricing model. The BSM model requires various highly judgmental assumptions including expected volatility and option life. If any of the assumptions used in the BSM model change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period. The fair values of our equity awards, primarily stock option grants, were estimated with the following weighted average assumptions:

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011     2010  

Dividend yield

     0     0     0     0

Expected life

     4 years        4 years        4 years        4 years   

Expected volatility

     73     73     74     72

Risk-free interest rate

     0.8     1.2     1.2     1.6

The impact on our results of operations of recording stock-based compensation expense for the three and nine months ended September 30, 2011 and 2010 was as follows (in thousands, except per share amounts):

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2011      2010      2011      2010  

Cost of revenue — service

   $ 184       $ 78       $ 560       $ 197   

Selling, general and administrative

     346         187         1,000         327   

Research and development

     48         11         125         30   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation expense

   $ 578       $ 276       $ 1,685       $ 554   
  

 

 

    

 

 

    

 

 

    

 

 

 

Per diluted share

   $ 0.05       $ 0.03       $ 0.14       $ 0.05   
  

 

 

    

 

 

    

 

 

    

 

 

 

Stock Option Activity

The following table summarizes stock option activity for the nine months ended September 30, 2011:

 

Stock Options

   Number of
Shares
    Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Life
(in years)
     Aggregate
Intrinsic
Value
 

Balance at January 1, 2011

     1,942,723      $ 3.66         

Granted at fair value

     423,215        7.93         

Exercised

     (172,867     2.84         

Forfeited

     (35,910     3.32         

Expired

     (114,682     6.02         
  

 

 

         

Balance at September 30, 2011

     2,042,479      $ 4.49         4.63       $ 1,999,000   
  

 

 

   

 

 

    

 

 

    

 

 

 

Vested and expected to vest at September 30, 2011

     1,935,135      $ 4.39         4.53       $ 1,939,000   
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable at September 30, 2011

     1,393,341      $ 3.87         3.78       $ 1,542,000   
  

 

 

   

 

 

    

 

 

    

 

 

 

At September 30, 2011, total compensation cost related to stock options granted to employees but not yet recognized was $1,130,000, net of estimated forfeitures. This cost will be amortized on the straight-line method over a weighted-average period of approximately 1.62 years.

 

The following table summarizes certain information about stock options for the three and nine months ended September 30, 2011 and 2010:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2011      2010      2011      2010  

Weighted-average grant-date fair value of option grants for the period

   $ 3.67       $ 1.89       $ 4.52         1.71   
  

 

 

    

 

 

    

 

 

    

 

 

 

Options in-the-money at period end

     1,040,047         874,328         1,040,047         874,328   
  

 

 

    

 

 

    

 

 

    

 

 

 

Aggregate intrinsic value

   $ 119,000       $ 20,000       $ 871,000       $ 26,000   

The aggregate intrinsic value represents the difference between the exercise price of the underlying options and the quoted price of our common stock for the number of options that were in-the-money at period end or that were exercised during the period. We issue new shares of common stock upon exercise of stock options.

Restricted Stock Award Activity

The following table summarizes RSA activity for the nine months ended September 30, 2011:

 

     Number of
Shares
    Weighted
Average
Grant-Date
Fair Value Per
Share
 

Unvested at December 31, 2010

     42,000      $ 3.38   

Granted

     30,000        6.58   

Vested

     (36,000     3.26   

Forfeited

     —          —     
  

 

 

   

 

 

 

Unvested at September 30, 2011

     36,000      $ 6.17   
  

 

 

   

 

 

 

Expected to vest after September 30, 2011

     32,400      $ 6.47   
  

 

 

   

 

 

 

At September 30, 2011, total compensation cost related to RSAs granted but not yet recognized was $100,000, net of estimated forfeitures. This cost will be amortized on the straight-line method over a period of approximately 0.5 years. Currently, only non-employee members of our Board of Directors receive restricted RSAs. Compensation for non-employee Directors has been modified such that future equity compensation will be issued through RSUs.

Restricted Stock Unit Activity

The following table summarizes RSU activity for the nine months ended September 30, 2011:

 

     Number of
Shares
    Weighted Average
Grant Date Fair
Value
 

Unvested at December 31, 2010

     346,776      $ 4.47   

Granted

     146,966        5.88   

Vested

     (108,901     3.21   

Forfeited

     (29,760     4.75   
  

 

 

   

 

 

 

Unvested at September 30, 2011

     355,081      $ 5.34   
  

 

 

   

 

 

 

Expected to vest after September 30, 2011

     321,289      $ 5.33   
  

 

 

   

 

 

 

At September 30, 2011, total compensation cost related to RSUs granted but not yet recognized was $1.0 million, net of estimated forfeitures. This cost will be amortized on the straight-line method over a period of approximately 2.0 year.

 

Common Stock Reserved for Future Issuance

The following table summarizes our shares of common stock reserved for future issuance at September 30, 2011:

 

     September 30,
2011
 

Stock options outstanding

     2,042,479   

Restricted stock units outstanding

     355,081   

Stock options available for future grant

     590,830   
  

 

 

 

Common stock reserved for future issuance

     2,988,390